Item 2.02 Results of Operations and Financial Condition.

On May 10, 2021, VBI Vaccines Inc. issued a press release announcing its financial results for the first fiscal quarter ending March 31, 2021 and provided a corporate update. A copy of this press release is furnished as Exhibit 99.1 hereto and is incorporated herein by reference.

In accordance with General Instruction B.2 of Form 8-K, the information in this Current Report on Form 8-K, including Exhibit 99.1, that is furnished pursuant to this Item 2.02 shall not be deemed to be "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

Item 9.01 Financial Statements and Exhibits.





(d) Exhibits



Exhibit No.   Description

99.1            Press Release dated May 10, 2021*

* This exhibit is furnished pursuant to Item 2.02 and shall not be deemed to be "filed."

© Edgar Online, source Glimpses